September 21st, 2014

Parkinson’s Drug Recall

 

Parkinson’s Drug Recall

September 4, 2014
Nearly 4,000 bottles of a Parkinson’s combination drug are being pulled from shelves, according to the U.S. Food and Drug Administration.

The U.S. nationwide recall is due to what may potentially be ‘superpotent’ carbidopa/levodopatablets.

This recall comes on the heels of a recall in April and June for the Israeli generic drug maker.

 

References:

1. Teva Recalling ‘Superpotent’ Drug for Parkinson’s Disease. FDANews. 2014 Aug 27.

2. Palmer E. Teva recalls Parkinson's disease drug because it may be 'superpotent'. Fierce Pharma. 2014 Aug 26.

PLN Topics:
Medication Errors
RELATED ARTICLES
Baxter Recalls Potassium Chloride Injection
Heparin Recall Due to Human Hair
Warfarin Sodium Tablets Recall
FDA Issues Reminder to Avoid Products from Texas Compounder
Compounding Pharmacy Recall